SCHEMBL9111263

SCHEMBL9111263

[CH2]CC=CC=CC1CCCCN1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL817848 0.76
SCHEMBL22767577 0.74
SCHEMBL9111671 0.74
SCHEMBL23436798 0.73 SLC6A2 (0.33) SLC6A2SLC6A4SLC6A3
SCHEMBL9112814 0.73 CYP2D6 (0.30) SLC6A2SLC6A4SLC6A3
SCHEMBL9112249 0.72
SCHEMBL21533040 0.71
SCHEMBL14032382 0.71 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3
SCHEMBL818813 0.70
SCHEMBL9114181 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed